Biomedical subjects
Publications and source records attributed to M R Prince.
Gadolinium-enhanced MR angiography provides contrast arteriograms without the risks of arterial catheterization or iodinated contrast. Although this technique is in the early stages of development, already it has yielded promising images of large vascular structures without degradation from flow artifacts. As the technique is developed and further optimized, higher resolution and greater arterial detail will become possible.
Three-dimensional contrast-enhanced magnetic resonance (MR) angiography is a relatively new technique that uses the transient shortening in blood T1 following the intravenous injection of gadolinium chelates to image blood vessels irrespective of flow. For many applications, 3D contrast-enhanced MR angiography is developing into a safe, fast, and cost-effective alternative to conventional diagnostic angiography. One of its biggest advantages over other MR angiography techniques (and CT angiography) is the ability to image in a plane parallel to the vessel of interest. This feature, combined with the inherent properties of a 3D gradient refocused sequence, make 3D contrast-enhanced MR angiography intrinsically fast, high resolution and free from saturation and turbulence-related artifacts. This article is designed to familiarize the reader with the theory of 3D contrast-enhanced MR angiography and the application of the technique to different vascular territories. Contrast agents, relaxation effects, contrast bolus effects, pulse sequences, artifacts, and post-processing, as well as the present state of thinking with regard to optimal contrast injection timing/detection and Fourier space mapping are discussed. Patient preparation and techniques and imaging parameters for body applications of gadolinium-enhanced MR angiography, including aorta, renal arteries, mesenteric arteries, portal venous system, pelvis and legs, pulmonary arteries, and carotid arteries are included.
PURPOSE: The objective of this study was to assess the usefulness of gadolinum-enhanced magnetic resonance angiography (MRA) for defining anatomic features relevant to performing aortic surgery for aneurysmal disease. METHODS: Anatomic data defined by MRA, including abdominal aortic aneurysm (AAA) size and character, as well as the status of the celiac, mesenteric, renal, and iliac arteries, were correlated with angiography, ultrasonography, computed tomography, or operative data in 43 patients. Five MRA sequences were obtained in an hour-long examination optimized for aortoiliac, splanchnic, and renal artery imaging at 1.5 T in a body coil. Four of the sequences were performed during or after infusion of gadolinium to improve image quality. RESULTS: MRA correctly defined the maximum aneurysm diameter, as well as its proximal and distal extent in all patients. MRA detected 33 of 35 significant stenoses among 153 splanchnic, renal, or iliac branches examined (sensitivity = 94% and specificity = 98%). MRA did not resolve the degree of aortic branch stenotic disease sufficiently to precisely grade its severity. MRA did not reliably define the status of the inferior mesenteric artery, lumbar arteries or internal iliac arteries. One ruptured AAA and one inflammatory AAA were correctly diagnosed by MRA. No patient had a contrast reaction or contrast-induced renal toxicity related to administration of gadolinium. CONCLUSION: Gadolinium-enhanced MRA of AAA provides appropriate, essential anatomic information for aortic reconstructive surgery in a 1-hour examination devoid of contrast-related renal toxicity or catheterization-related complications attending conventional arteriography.
PURPOSE: To develop and evaluate a sequence for breath-hold three-dimensional gadolinium-enhanced magnetic resonance (MR) angiography of the abdominal aorta. MATERIALS AND METHODS: In 63 patients, the abdominal aorta and its branches were imaged for 29, 43, or 58 seconds with breath holding. A fast spoiled gradient-echo sequence was used at 1.5 T during infusion of 42 mL of a gadolinium chelate. Correlation with conventional angiography was performed in 19 patients. MR image quality (signal-to-"total" noise ratio [S/N*]) with breath holding was compared with that with free breathing (104 patients). RESULTS: With breath-hold gadolinium-enhanced MR angiography, renal, celiac, and superior mesenteric artery occlusive disease was graded appropriately in 15 of 19 patients, and 10 of 11 accessory renal arteries were depicted correctly. Renal artery branches were visualized in 86 of 95 kidneys on breath-hold images compared with only 84 of 236 kidneys with free breathing (P < .001). Distal renal artery S/N* was 3.1 with breath holding and 2.1 with free breathing (P < .001). CONCLUSION: Breath holding statistically significantly improves three-dimensional gadolinium-enhanced MR angiography of the renal, celiac, and superior mesenteric arteries.
PURPOSE: To evaluate the potential for preferential arterial enhancement at magnetic resonance (MR) aortography with an intravenous infusion of paramagnetic contrast material. MATERIALS AND METHODS: Gadolinium chelates were administered intravenously (0.2 mmol/kg) during three-dimensional MR imaging (1.5 T) in 125 patients (77 male and 48 female patients, aged 4-86 years [mean, 66 years]) with suspected aorta or aortic branch vessel disease. RESULTS: Infusion for the duration of the MR acquisition resulted in significant preferential arterial enhancement without the confounding effects of excessive venous or background-tissue enhancement (P < 10(-5)). Angiographic or surgical correlation in 48 patients revealed an 88% sensitivity and a 97% specificity for detection of stenoses or occlusions and a 100% sensitivity and a 100% specificity for detection of aortic or iliac artery aneurysms. CONCLUSION: Preferential arterial enhancement is possible at MR aortography with an intravenous infusion of paramagnetic contrast material.
OBJECTIVE: The purpose of this report is to compare the results of MR imaging, including MR angiography, with the results of conventional angiography in the imaging of abdominal aortic aneurysms (AAA). SUBJECTS AND METHODS: Twenty seven nonconsecutive patients with known AAA underwent both MR imaging (including MR angiography) and conventional angiography preoperatively. MR imaging was done before angiography according to the following protocol in all patients: sagittal and coronal T1-weighted images of the abdomen, followed by axial MR angiograms obtained with a multiple overlapping thin-slab acquisition (MOTSA) three-dimensional time-of-flight (3D TOF) volume centered on the renal arteries. Last, coronal MR angiograms were obtained with a dynamic contrast-enhanced 3D TOF volume centered on the aorta. Conventional angiography was subsequently performed in all patients. Data from each study were collected prospectively and analyzed in a blinded manner. For the MR studies, all sequences were used to determine the extent of the AAA and the presence of iliac aneurysms; stenotic disease of the celiac, superior mesenteric, renal, and iliac arteries and the number and location of renal arteries were determined from the MR angiograms. For evaluation of the extent of the aneurysm, results from both techniques were compared with surgical results; otherwise MR angiography was compared with conventional angiography. Confidence intervals for sensitivity and specificity were calculated at the 95% level. The McNemar test was used for comparison of proportions. RESULTS: MR angiography had a sensitivity of 100% (4/4) and a specificity of 91% (21/23) for the four stenoses of the celiac artery that were greater than 50%. For detection of renal artery stenoses of greater than 50%, present in nine arteries, the sensitivity was 89% (8/9) and specificity was 98% (49/50). MR angiography showed 100% (54/54) of all main renal arteries and 78% (7/9) of all accessory renal arteries seen on conventional angiograms. The proximal extent of the aneurysm was correctly predicted on the basis of MR findings in 100% (26/26) of patients with surgical correlation, compared with 92% (24/26) when conventional angiograms were used. This difference was not statistically significant (p > .1). MR imaging had a sensitivity of 100% (19/19) for detection of isolated aneurysms of the common iliac artery, and MR angiography had a 100% sensitivity (5/5) and specificity (103/103) for detection of stenosis greater than 50% in the common and external iliac arteries. One circumaortic left renal vein was visualized on MR images. CONCLUSION: These results suggest that MR angiography may be a useful noninvasive method for determining the presence of coexistent celiac, superior mesenteric, renal, and iliac atherosclerotic disease in patients with AAA.
The yellow color of atherosclerotic plaque is due to the presence of carotenoids, which absorb light between 430-530 nm and account for the preferential ablation of plaque by the pulsed dye laser operating at 480 nm. This study was designed to examine tissue uptake of beta-carotene and the effect of uptake on arterial plaque ablation. Forty-two atherosclerotic NZW rabbits were given intravenous beta-carotene at a dose of 40 mg/kg, twice weekly and killed between 1 hour and 28 days after the initial injection. beta-carotene was not detected in control specimens but was significantly greater in plaque than in normal wall at all time points following beta-carotene injection (P < 0.04 Mann Whitney U test). The ablation threshold was significantly lower in beta-carotene treated plaque than in untreated plaque or normal arterial wall (P < 0.01, Fisher's exact test). In this model beta-carotene is preferentially taken up into arterial plaque, resulting in increased absorption of laser radiation at 480 nm and enhanced tissue ablation.
The accumulation of beta-carotene in serum and skin was evaluated in human volunteers. A single 51-mg dose of beta-carotene given in the absence of dietary fat resulted in no detectable change in serum beta-carotene. The same dose administered with 200 g fat increased serum beta-carotene 2.5-fold at 40 h. Similarly, administering beta-carotene daily in three divided doses with meals raised the serum beta-carotene concentration three times as high compared with the same total dose administered once a day; both regimens had the same time constant for serum accumulation; 9-10 d. Remittance measurements of skin color demonstrated that the accumulation of beta-carotene in skin was delayed by up to 2 wk compared with serum accumulation. These data indicate that beta-carotene absorption requires dietary fat and is enhanced by administering with meals but there is a long time constant for serum (10 d) and tissue (several weeks) accumulation.
Explore the source record for details and available documents.
The kinetics of serum beta-carotene loading were evaluated to help determine the minimum time required to load fatty tissues, including atherosclerotic plaque and skin, with beta-carotene. Loading atherosclerotic plaque with yellow beta-carotene pigment increases absorption of blue laser radiation, potentially enhancing the selectivity and quality of laser angioplasty. Five healthy volunteers received 300 mg beta-carotene daily (the maximum FDA recommended dose) for 21 days in three divided doses with meals. Serum total carotenoid levels increased exponentially with a 10-day time constant from an average of 1.7-6.5 micrograms/ml (p less than 10(-4]. The skin began to yellow visibly at 10 days and became increasingly yellow for several weeks thereafter, suggesting that augmenting the yellow color of fatty tissues and atherosclerotic plaque with oral beta-carotene may require a minimum of several weeks to attain the maximum effect.
Explore the source record for details and available documents.
Laser angioplasty systems with laser energy preferentially absorbed by atherosclerotic plaque may offer a safe method of plaque removal. This study evaluated the effect of blood upon selective energy absorption using a pulsed dye laser at 480 nm. Intra-arterial laser irradiation of normal rabbit femoral arteries demonstrated a perforation threshold energy with blood perfusion of 13.1 mJ per pulse compared to 87.9 mJ with saline (P less than .0001), indicating a deleterious effect in the presence of blood. An adverse effect upon arterial healing at 3 days was noted in sheep following intra-arterial irradiation during blood but not saline perfusion. Normal and atherosclerotic human aorta ablation thresholds differed significantly (P less than .0002) under saline (plaque: 20 mJ and normal: 120 mJ) but the difference under blood (plaque: 5 mJ and normal: 20 mJ) was not significant. We conclude that absorption of laser energy by blood can reduce the effect of differential absorption by endogenous chromophores in normal and pathologic vascular tissues and, therefore, removal of blood may be a prerequisite for selective ablation of atherosclerotic plaques.
Selective laser ablation of human atherosclerotic plaque is possible because endogenous carotenoid pigments found in atherosclerotic plaque confer a twofold preferential absorption of laser radiation at 450 to 500 nm. In this study, patients with carotid endarterectomy were pretreated with oral beta carotene to determine if the carotenoid content and therefore laser selectivity of plaque could be increased in vivo. Beta carotene-treated patients had a significant, nearly twofold increase in their plaque carotenoid concentration, which increased from 0.22 to 0.40 microgram beta carotene/mg cholesterol. These results suggest that selective ablation of atherosclerotic plaque may be enhanced by pretreating patients with doses of oral beta carotene for short periods of time.
The effect of varying pulse duration on selective ablation of human arterial plaque was evaluated by measuring ablation thresholds and ablation efficiencies on fresh human fibrofatty plaque, calcified plaque, normal intima, deep media, and adventitia using 480- to 490-nm laser radiation at 1, 8, and 50-microseconds pulse durations. For all tissues examined, the ablation threshold energy increased with increasing pulse duration, but the threshold for normal tissue ablation was approximately twice that of plaque at all pulse durations. Ablation efficiency was studied at a fluence that was twice the ablation threshold for plaque. For those fluences, normal intima had detectable ablation only at 50 microseconds. The ablation efficiency of fibrofatty plaque was minimally reduced with prolongation of pulse duration; however, there was a substantial decrease in the ablation efficiency of calcified plaque when the pulse duration was lengthened from 8 to 50 microseconds. These data show significant selective ablation of fibrofatty and calcified plaque at 1, 8, and 50 microseconds and suggest that the optimal pulse width for selective ablation of all plaque in the 480- to 490-waveband is less than 50 microseconds.
Laser radiation was employed to ablate venous thrombus or emboli with parameters that would not injure endovascular tissues. Output from a 482-nm, 1-microsec pulsed dye laser was delivered through a 320-microns-diameter fiber to in vitro samples of fresh thrombus (T), venous or pulmonary emboli (VE), inferior vena cava (IVC), pulmonary artery (PA), pulmonary valve, and endocardium (atrial and ventricular). The mean threshold fluences for ablation of T and VE were 1.1 and 5.1 J/cm2, respectively. In contrast, the mean threshold fluences for IVC and PA were significantly higher (P less than 0.0001), at 120 and 124 J/cm2, respectively. Ablation efficiency of thrombus was in excess of 100 mg/J, under conditions that caused no histologic injury to the pulmonary artery. To correlate ablation studies with optical absorption by the tissues, optical properties of fresh T, VE, IVC, and PA were studied. Hemoglobin species accounted for the more than 10 times higher 482-nm absorption by T and VE compared to IVC and PA. This explains the differences in ablation thresholds and, thus, the selectivity encountered. These observations demonstrate, more than any other study in the vascular system, that with pulsed optical radiation, efficient laser ablation of venous thrombus is feasible with a wide margin of safety, and without damage to the surrounding vascular tissue.
To determine the biocompatibility and thrombogenicity of nitinol blood clot filters, we inserted 27 nitinol wire devices into the venae cavae of 16 dogs and one sheep and studied the results angiographically and at autopsy after periods of one week to four years. Filter shape, location in the vena cava, wire cleaning procedure and wire surface finish were varied. All 18 cleaned nitinol wire filters remained patent by venogram, although some showed small venographic filling defects caused by adherent organized thrombi. Filters in larger veins tended to have less thrombus. Surface polishing and filter shape had no observable effect on thrombogenicity. Histologic study revealed patchy chronic inflammation at the surface of uncleaned filters but only benign fibrous tissue reaction for the cleaned filters. Neointimal tissue overgrowth was observed where nitinol wire contacted the wall of the vena cava. Two filters implanted for four years had no appreciable weight loss caused by corrosion. Platelet adhesion and plasma coagulation effects of nitinol wire were tested in vitro in human blood and found to be similar to those of stainless steel, which is used in comparable devices. These encouraging results suggest that nitinol may be a promising material for human intravascular prosthetic applications.
Patients undergoing carotid endarterectomy were pretreated with low-dose, oral beta carotene to determine whether the carotenoid content of plaque could be increased in vivo. Beta carotene-treated patients had a 50-fold increase in their plaque beta carotene level from 0.066 to 3.3 micrograms beta carotene/g plaque. Microscopy and microspectrophotometry demonstrated that plaque from beta carotene-treated patients had higher carotenoid levels and higher absorption (450-500 nm) compared with control specimens, but normal media was unaffected. This demonstration of increased preferential absorption by plaque suggests that selective ablation of atherosclerotic plaque may be enhanced by pretreating patients with oral beta carotene.